...
首页> 外文期刊>Journal of vascular surgery >Report on endograft management of traumatic thoracic aortic transections at 30 days and 1 year from a multidisciplinary subcommittee of the Society for Vascular Surgery Outcomes Committee.
【24h】

Report on endograft management of traumatic thoracic aortic transections at 30 days and 1 year from a multidisciplinary subcommittee of the Society for Vascular Surgery Outcomes Committee.

机译:血管外科手术结果委员会多学科小组委员会在30天和1年时报告了创伤性胸主动脉横切术的内膜移植治疗。

获取原文
获取原文并翻译 | 示例

摘要

OBJECTIVES: The Society for Vascular Surgery Outcomes Committee, including ad hoc members from Society of Thoracic Surgeons, American Association of Thoracic Surgery, and Society for Interventional Radiology, collected outcomes of patients with traumatic thoracic aortic transections treated with endovascular grafts. Results through 1 year of follow-up are reported. METHODS: Data from five physician-sponsored investigational device exemption clinical trials from 2000 to 2008 were entered using standardized forms and definitions. Adverse events were reported early (30 days) by body system. Major adverse events included one or more of the following: death, stroke, myocardial infarction, renal failure, respiratory failure, paralysis, or bowel ischemia. RESULTS: There were 60 symptomatic patients (68.3% men; mean age, 46 years) with traumatic aortic transections, of which 97% were due to a motor vehicle accident and 3% were related to other blunt trauma. The average total injury severity score was 39, most with involvement of the chest and abdomen. The average surgical time was 125 minutes. The mean hospital length of stay was 17 days. Associated procedures for the management of nonaortic injuries occurred in 51.7%. All-cause mortality was 9.1% at 30 days and 14.4% at 1 year. One or more major adverse events occurred in 23.3% of the patients, major adverse events occurred early in 20.0% and late in 3.6%. Death accounted for 41.7% of the early and all of the late major adverse events. Early adverse events included 16.7% pulmonary, 13.3% neurologic, and 11.7% vascular complications. Late adverse events included one patient (1.8%) with pulmonary failure and one patient (1.8%) who died of an unknown cause. CONCLUSIONS: One-year results of endograft placement for the management of patients with traumatic aortic injury are acceptable. Most cases treated were due to motor vehicle accident and associated with multiple coexisting injuries. Approximately three-quarters of the deaths occurred
机译:目标:血管外科手术结果委员会,包括来自胸外科医师学会,美国胸外科医师协会和介入放射学学会的特设成员,收集了经血管内移植物治疗的具有创伤性胸主动脉横断的患者的预后。报告通过1年的随访结果。方法:采用标准化的形式和定义,输入了2000年至2008年的五项由医师赞助的研究器械豁免临床试验的数据。身体系统报告了不良事件发生的早期( 30天)。主要不良事件包括以下一种或多种:死亡,中风,心肌梗塞,肾衰竭,呼吸衰竭,瘫痪或肠缺血。结果:60例有症状的主动脉横断患者(男性68.3%;平均年龄46岁),其中97%是由于机动车事故造成的,3%与其他钝性创伤有关。平均总损伤严重程度评分为39,大多数情况下累及胸部和腹部。平均手术时间为125分钟。平均住院时间为17天。发生非主动脉损伤的相关程序为51.7%。 30天时全因死亡率为9.1%,一年时为14.4%。 23.3%的患者发生一种或多种主要不良事件,主要不良事件发生在早期的20.0%和晚期的发生在3.6%。死亡占早期和所有晚期重大不良事件的41.7%。早期不良事件包括16.7%的肺部疾病,13.3%的神经系统疾病和11.7%的血管并发症。晚期不良事件包括一名肺衰竭患者(1.8%)和一名死因不明的患者(1.8%)。结论:对于外伤性主动脉损伤患者,一年内移植治疗的结果是可以接受的。所治疗的大多数病例是由于机动车事故造成的,并伴有多处并存的伤害。大约四分之三的死亡发生

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号